| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
William W King, Raymond Richhart, Tyler Culpepper, Maneola Mota, Debdeep Banerjee, Media Ismael, Joydeep Chakraborty, Michael Ladna, Walid Khan, Nicole Ruiz, Jake Wilson, Ellery Altshuler, Virginia Clark and Roniel Cabrera |
| Funding Agency and Grant Number |
|
| Corresponding Author |
William W King, MD, Doctor, Doctor, Department of Medicine, University of Florida, 1600 SW Archer Rd
Room 4102, Gainesville, Florida 32610, United States. william.king@medicine.ufl.edu |
| Key Words |
Hepatocellular carcinoma; Cirrhosis; Health maintenance; Quality improvement; Screening; Hepatology |
| Core Tip |
This study reinforces existing knowledge that screening rates for Hepatocellular carcinoma are woefully inadequate, even in a subspecialty hepatology clinic. Unlike previous studies, ours identifies specific failure points, showing that screening failures are driven more by systemic issues than by physician or patient error. |
| Publish Date |
2023-03-22 11:20 |
| Citation |
King WW, Richhart R, Culpepper T, Mota M, Banerjee D, Ismael M, Chakraborty J, Ladna M, Khan W, Ruiz N, Wilson J, Altshuler E, Clark V, Cabrera R. Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience. World J Hepatol 2023; 15(3): 410-418 |
| URL |
https://www.wjgnet.com/1948-5182/full/v15/i3/410.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v15.i3.410 |
